
Young cancer survivors face a heightened risk from human papillomavirus (HPV), a virus known to raise the risk of cervical cancer. So why are they getting the HPV vaccine in low numbers? To find out, researchers analyzed data from a clinical trial of the HPV vaccine among cancer survivors who were ages 9 to 26… read on > read on >